Pharmadule Morimatsu wins FMCG design order

news-releasesPharmadule Morimatsu AB
March 13th 2017
Nacka, Stockholm: – Pharmadule Morimatsu AB the Swedish-based world-wide turnkey supplier specialist in modular construction, facility engineering and process equipment, has won an important new design order from the fast-moving consumer goods (FMCG) sector.

The order from a highly recognized UK-based FMCG multinational corporation covers design studies for new modular facility production lines at two different global locations.

The study will initially involve engineering departments at Pharmadule’s Stockholm headquarters.

Facility, quality and regulatory expertise

The study will be completed during Q1 2017, with scope of delivery to include Facility, Quality and Regulatory disciplines.

“This project provides further proof that Pharmadule Morimatsu’s modular facility solutions and engineering services are highly attractive on the worldwide market and across a wide range of industries,” said Pharmadule Morimatsu Business Development Director, Leo Fällgren.

“We are very proud to have won this order in our 30th anniversary year and to have our expertise recognized by a leading global FMCG supplier,” Mr. Fällgren added.

About Pharmadule Morimatsu

Pharmadule Morimatsu designs and builds turnkey production facilities for the pharma and biopharma Industries. Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.

The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.

Since then, Pharmadule has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.